Sanofi SA Cash Flow Conversion Efficiency

Latest as of December 2025: 0.152x

Sanofi SA cash flow conversion efficiency. Based on the latest financial reports, Sanofi SA (SAN) has a cash flow conversion efficiency ratio of 0.152x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€10.92 Billion ≈ $12.76 Billion USD) by net assets (€71.71 Billion ≈ $83.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sanofi SA (1999–2025)

Cash flow conversion efficiency of Sanofi SA from 1999 to 2025. This chart illustrates how Sanofi SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SAN live share price for real-time trading data and today's change.

Sanofi SA Cash Flow Conversion Ratio Explained

Sanofi SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sanofi SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sanofi SA ranked by their cash flow conversion efficiency. Also see SAN market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Compagnie Financière Richemont SA JSE:CFR	0.035x
State Bank of India NSE:SBIN	-0.265x
ROLLS ROYCE H.ADR/ LS-20 F:RRU1	N/A
Duke Energy Corporation NYSE:DUK	0.049x
Mizuho Financial Group Inc F:MZ8A	N/A
Enel SpA F:ENLA	0.103x
PROSUS NV ADR/ 1/1 F:1YL	N/A
The Bank of New York Mellon Corporation NYSE:BK	-0.066x

Annual Cash Flow Conversion Efficiency for Sanofi SA (1999–2025)

The table below shows the annual cash flow conversion efficiency of Sanofi SA from 1999 to 2025. Review Sanofi SA (SAN) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€71.71 Billion ≈ $83.84 Billion	€10.92 Billion ≈ $12.76 Billion	0.152x	+30.52%
2024-12-31	€77.86 Billion ≈ $91.02 Billion	€9.08 Billion ≈ $10.62 Billion	0.117x	-15.46%
2023-12-31	€74.35 Billion ≈ $86.93 Billion	€10.26 Billion ≈ $11.99 Billion	0.138x	-4.30%
2022-12-31	€73.02 Billion ≈ $85.36 Billion	€10.53 Billion ≈ $12.31 Billion	0.144x	-5.42%
2021-12-31	€69.03 Billion ≈ $80.70 Billion	€10.52 Billion ≈ $12.30 Billion	0.152x	+29.67%
2020-12-31	€63.37 Billion ≈ $74.08 Billion	€7.45 Billion ≈ $8.71 Billion	0.118x	-10.28%
2019-12-31	€59.11 Billion ≈ $69.10 Billion	€7.74 Billion ≈ $9.05 Billion	0.131x	+39.43%
2018-12-31	€59.03 Billion ≈ $69.02 Billion	€5.55 Billion ≈ $6.49 Billion	0.094x	-25.84%
2017-12-31	€58.24 Billion ≈ $68.09 Billion	€7.38 Billion ≈ $8.63 Billion	0.127x	-6.69%
2016-12-31	€57.72 Billion ≈ $67.49 Billion	€7.84 Billion ≈ $9.16 Billion	0.136x	-11.39%
2015-12-31	€58.21 Billion ≈ $68.05 Billion	€8.92 Billion ≈ $10.43 Billion	0.153x	+12.12%
2014-12-31	€56.27 Billion ≈ $65.78 Billion	€7.69 Billion ≈ $8.99 Billion	0.137x	+12.09%
2013-12-31	€57.03 Billion ≈ $66.68 Billion	€6.95 Billion ≈ $8.13 Billion	0.122x	-14.25%
2012-12-31	€57.47 Billion ≈ $67.18 Billion	€8.17 Billion ≈ $9.55 Billion	0.142x	-13.99%
2011-12-31	€56.37 Billion ≈ $65.91 Billion	€9.32 Billion ≈ $10.89 Billion	0.165x	-9.73%
2010-12-31	€53.29 Billion ≈ $62.30 Billion	€9.76 Billion ≈ $11.41 Billion	0.183x	+4.20%
2009-12-31	€48.45 Billion ≈ $56.64 Billion	€8.52 Billion ≈ $9.95 Billion	0.176x	-7.05%
2008-12-31	€45.07 Billion ≈ $52.69 Billion	€8.52 Billion ≈ $9.96 Billion	0.189x	+18.82%
2007-12-31	€44.72 Billion ≈ $52.28 Billion	€7.12 Billion ≈ $8.32 Billion	0.159x	+10.43%
2006-12-31	€45.82 Billion ≈ $53.57 Billion	€6.60 Billion ≈ $7.72 Billion	0.144x	+4.42%
2005-12-31	€46.32 Billion ≈ $54.15 Billion	€6.39 Billion ≈ $7.47 Billion	0.138x	+42.35%
2004-12-31	€41.52 Billion ≈ $48.54 Billion	€4.03 Billion ≈ $4.71 Billion	0.097x	-72.86%
2003-12-31	€6.33 Billion ≈ $7.40 Billion	€2.26 Billion ≈ $2.64 Billion	0.357x	+29.04%
2002-12-31	€6.06 Billion ≈ $7.08 Billion	€1.68 Billion ≈ $1.96 Billion	0.277x	-11.84%
2001-12-31	€5.79 Billion ≈ $6.77 Billion	€1.82 Billion ≈ $2.13 Billion	0.314x	+13.46%
2000-12-31	€4.33 Billion ≈ $5.06 Billion	€1.20 Billion ≈ $1.40 Billion	0.277x	+20.71%
1999-12-31	€3.61 Billion ≈ $4.22 Billion	€828.00 Million ≈ $968.02 Million	0.229x	--

About Sanofi SA

PA:SAN France Drug Manufacturers - General

Market Cap

$114.33 Billion

€97.79 Billion EUR

Market Cap Rank

#269 Global

#11 in France

Share Price

€80.98

Change (1 day)

+0.43%

52-Week Range

€69.99 - €90.44

All Time High

€109.62